Clinical Trial Update: Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Tenecteplase for reperfusion in acute ischemic stroke with unknown time of onset; currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Tenecteplase (tenecteplase)

Snippet

Sponsor: First Affiliated Hospital of Guangxi Medical University | Conditions: Acute Ischemic Stroke, Tenecteplase | Phase 3 | Status: NOT_YET_RECRUITING